drugset / Trial / NCT00139646

Parecoxib in Renal Colic

NCT00139646

Phase 3 Terminated 50 enrolled Pfizer
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pain due to renal colic.

Timeline

Start
2002-04
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified Intramuscular
Subject Parecoxib Small molecule Intramuscular

Indications

No indication recorded.